At the Department of Otolaryngology at the University of Michigan Health System, we are on the cutting-edge of diagnosing, treating and rehabilitating patients with diseases of the head and neck, also coordinating with our Comprehensive Cancer Center to expertly treat head and neck cancers.
Medical Services related to Melissa Ann Pynnonen MD
Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder that affects about one in 5,000 people and commonly causes nosebleeds, with more frequent nosebleeds typically starting after about age 12. Patients with HHT have a tendency to form blood vessels that are abnormal, fragile, and bleed more easily. Michigan Medicine has a multidisciplinary team of physicians to treat HHT, including specialists in otolaryngology (for nosebleeds), pulmonary diseases, interventional radiology, gastroenterology, neurosurgery, liver diseases, cardiology, heart failure, dermatology, radiation oncology, hematology-oncology and associated pediatric subspecialties.
There are many different specialists who treat patients with HHT. Many patients will eventually see two or more types of specialists, especially later in adulthood. Specialists who treat HHT include otolaryngologists (ear, nose & throat doctors), interventional radiologists (to treat AVMs), hematologists (to help manage anemia), and more.
One in seven Americans will develop a nosebleed (epistaxis) at least once in their lives. While nosebleeds are common and usually harmless, the sudden onset of a bloody nose can be startling and frightening. The most common causes for nosebleeds are dry climate, heated indoor air during winter months, steroid nasal sprays or direct injury to the nose.